Abstract A101: Dose-related suppression of rat oral carcinogenesis by the EGF receptor-tyrosine kinase inhibitor, gefitinib

Author(s):  
Thomas L. Horn ◽  
William D. Johnson ◽  
Ronald A. Lubet ◽  
Vernon E. Steele ◽  
David L. McCormick
Sign in / Sign up

Export Citation Format

Share Document